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ABSTRACT 
 
Antineoplastic treatment has a deleterious effect on intellectual functions, which is 
mainly attributable to radiotherapy. With the object of determining the 
neuropsychological disturbances associated with brain irradiation in the child, and to try 
to differentiate them from the effects caused by the other types of treatment (surgical 
and chemotherapy) as well as from the effects of the tumor itself, a cross-sectional study 
was carried out in 25 survivors of medial edge intracranial tumors. In order to monitor 
the effect of systemic chemotherapy on the cognitive functions, and the effect of 
prolonged absence from school, two control groups were formed, one made up of 
subjects treated with chemotherapy for extracranial tumors, and the other of patients 
with nonmalignant chronic disease. Neuropsychological functions were measured using 
the Spanish version of the Wechsler scale, as well as the following tests: Spreen-
Benton, ITPA and TALE scales, Yuste Memory Test, Thurstone Attention Test, and the 
Rey Complex Figure. 
 
In addition to a progressive decline found in the full scale intelligence quotient in 
children irradiated for intracranial tumors, variance analysis showed that these patients 
deteriorate mainly in visual attention and memory, but also significantly in verbal 
fluency and in the Performance Intelligence Quotient and all its subtests, when 
compared to the control groups. Visual attention and the Wechsler Picture Arrangement 
and Block Designs, were the tests whose decline correlated with the total radiation 
administered. The article relates this specific neuropsychological injury with the total 
brain irradiation dose but also with the structures located in the cone-down fields of 
irradiation to boost regions in the middle edge intracranial content. 
 
 
KEY WORDS 
 
Intracranial tumors 
Cognitive sequelae  
Radiotherapy 
Chemotherapy 
 
 
 
Address reprint requests to A. García-Pérez MD 
Unidad de Neurología Infantil, Clínica Universitaria de Navarra. 
Apartado de Correos 192, 31080-Pamplona, Spain. 
 
 INTRODUCTION 
 
At the present time, 1 in every 1,000 adults in the 20-year-old age group is a survivor of 
childhood cancer [1]. Central nervous system (CNS) tumors take second place after 
leukemia in the league chart of most frequent malignant conditions suffered in 
childhood, representing about 20% of these kinds of illnesses suffered in childhood and 
adolescence [2]. Radiotherapy (RT) is an important treatment modality used for child 
intracranial tumors (ICT). This treatment requires the delivery of radical irradiation, 
usually after surgery, and sometimes followed by whole-brain prophylactic irradiation 
in order to sterilize any possible ICT extension [3]. Post-mortem examinations reveal 
that the physiopathological changes produced in the CNS by radiation and 
chemotherapy (CT) have been described as a necrotizing leukoencephalopathy and a 
mineralizing microangiopathy [4,5]. The increase in life expectancy brought about by 
the use of megavoltage radiation has enabled the effect on cognitive functions [6-8]. 
Given that 70% of both supra and infratentorial ICT in children are extrahemispherical 
[9], the posttreatment effect on functional motor handicaps is minimal, whilst the 
deleterious effect on neurophysiological abilities is far more significant. 
 
With the aim of evaluating the effect of RT on intellectual functions, several studies 
have been carried out on children with leukemia treated with CNS irradiation. In this 
type of condition the deterioration of cognitive functions can only be attributed to the 
iatrogenic effect of the treatment [10-15]. These studies, however, have one principal 
drawback: all the patients receive the same total dose (1,800 or 2,400 cGy), which is 
relatively low compared to that usually used in the treatment of ICT. The aims of the 
present study on children treated by RT for brain tumors were: a) to verify a deleterious 
effect on intellectual function produced by RT in these children, attempting to 
differentiate it from that produced by other types of treatment (surgery and CT) and the 
tumor itself; and b) to evaluate the possible correlation between the dose of the RT with 
the degree of neuropsychological deterioration. How this deterioration progresses on 
time and if the specific intellectual functions affected by the RT vary as a function of 
the age at which the irradiation is given, has been published separately [16]. 
 
 
 
MATERIALS AND METHODS 
 
Between 1980 and 1990, 63 children with ICT were seen in the Clínica Universitaria de 
Navarra (Service of Pediatric Oncology, Service of Child Neurology, and Service of 
Radiotherapy). All of them were treated with the conventional doses of RT in a radical 
therapy attempt. Correlatively 25 of them were taken into account for this study on the 
basis that they satisfied the following criteria: 1) ≤ 15 years old when treated; 2) normal 
psychomotor development up to the commencement of RT; 3) that in every case the 
tumor was of middle edge and extra-hemispheric, maintaining the integrity of the 
cerebral hemispheres insofar as the direct action of the tumor and surgery are 
concerned; 4) that 6 months had elapsed since treatment, allowing a reasonable time for 
the patient to recover from the effects of surgery and intracranial hypertension, so that 
only the neuropsychological sequelae of the treatment (CT, RI) would remain. The 
types and location of the tumors are set out in Table I. 
 
Two control groups of 25 children each were established (Table II). In order to control 
the possible effect on cognitive functions produced by CT the first group consisted of 
patients who had received CT for extracranial tumors (ECT), since some of the patients 
with ICT had received (CT) in addition to RT. The second group were patients with 
nonmalignant chronic illness (CHR) in order to control the effects of prolonged absence 
from school and the emotional disorders caused by serious illness. 
 
The children in these groups were matched with the index group for duration of 
posttreatment period, age at neuropsychological assessment, and in parental socio-
economic status, graded as (1) primary schooling and low-level employees or manual 
jobs or (2) secondary/ university degrees and technical/intellectual jobs. The preillness 
intelligence quotient (IQ) was also similar in the three groups, according to the school 
intelligence tests carried out before the development of illness. If this information was 
unavailable, IQ level was estimated by a team of school psychologists on the basis of 
preillness school grades. The homogeneity of the three groups in the duration of 
posttreatment period, age at neuropsychological assessment, IQ preillness, and parental 
sociocultural level was provided statistically (t-test, Mann-Whitney U test, chi-square, 
and correlation testing). 
 
In order to quantify the different types and doses of the RT received by the children, an 
RT score was established by a senior radiotherapist for use with statistical analysis. This 
score was: cGy of whole-brain RT + (cGy of in-volved field RT x the ratio of the brain 
volume included in the boost). The volume of the geometric figure closest to the brain 
volume radiated in the boost, according to measures given by X-ray simulation films, 
divided by whole-brain volume (equivalent to sum of a semisphere plus a semiovoid 
with the measures given by X-ray simulation films), gave the ratio of the encephalic 
volume radiated in the boost. 
 
In order to quantify the CT given to the ICT and ECT, a CT score was also established. 
Since the high doses of methotrexate (MTX) intravenously (i.v.) or the MTX-IT are 
reported to have a harmful effect on the CNS [4], every 6 g i.v. of MTX or every 
conventional administration of MTX-IT was quantified as 1 point. And so was 
considered as 1 point every dose of CT intra-arterial (i.a.) given directly to the brain 
(CDDP i.a., BCNU i.a., THIO i.a.). Finally, every whole i.v. administration of other CT 
agents, since they are not reported to be deletereous for the brain, was only quantified as 
0.1 point. 
 
The neuropsychological assessment was performed using the full and specific scores of 
the Spanish version of the Wechsler scale [17], as well as the following (Table III): 
Spreen-Benton [18] , ITPA [19] and TALE scales [20], Yuste Memory Test [21], 
Thurstone Attention Test [22], and the Rey Complex Figure [23]. The WISC-R was not 
used because it had not been standardized on Spanish children at the time of our study. 
Standardized scores were used where available, and direct test scores were not (Table 
IV). This was possible because the ages of the three groups had been matched. 
 
Statistical analysis (one-way variance and mean homogeneity analysis) was carried out 
using parametric and nonparametric statistics, according to whether or not the data were 
distributed in a normal or uniform manner. Distribution of the data was analyzed by a 
"normality test" (Statworks). A linear regression test was applied to relate the degree of 
cognitive deterioration (test scores) to the dose of RT administered (RT score). 
Significance was set at 5%. 
  
 
RESULTS 
 
The 25 children with ICT were assessed at time intervals from 6 months to 10 years 
after treatment. The neuropsychological assessment state of the patient population was 
as follows: 56% had full scale intelligence quotient (FSIQ) greater than 90; 28% had 
FSIQ level between 70 and 90; and 16% had FSIQ lower than 70. 
 
Comparing preillness IQ and the IQ at our assessment, the decline in FSIQ level was 
from a mean of 110.2 to a 92, and the drop was as follows: 23% of the patients 
experienced a drop of 10 points from their FSIQ score prior to RT; 29.5% dropped 
between 10- to 20 points; and 23.5% lost more than 30 points from their 
preradiotherapy FSIQ score. In the other groups the mean IQ pre and postillness were in 
the ECT 107.07 and 107.04, respectively, and in the CHR 108.1 and 106.92. 
 
The FSIQ deteriorated progressively. Among children assessed less than 3 years after 
RT 31% showed an FSIQ less than 90 with an average fall of 17.6 points, however, of 
those assessed at least 3 years after RT, 58% had an FSIQ of less than 90 and an 
average fall of 22.3 points (Fig. 1). 
 
Table IV records the means and variation values in the three groups of patients for all 
the tests applied. The statistical analysis among groups, using parametric and 
nonparametric tests, shows that the ICT patients present statistically significant 
differences in FSIQ, Performance IQ (PIQ) and all its subtests (Picture Completion, 
Picture Arrangements, Object Assembly, Coding, and Block Designs), verbal fluency, 
visual attention, and verbal and visual memory (Tables V and VI). 
 
To investigate the influence of the dose of RT on the severity of the sequelae, we 
performed two types of analyses. First, a regression analysis was carried out between 
the standardized scores of the tests and the RT administered (RT score). Significant 
regression emerged in the Wechsler performance subtest Block Design (r = 0.45/ P = 
0.03) and in the Visual Attention test (r = 0.52/ P = 0.01). Second, we divided the group 
of children into two subgroups according to whether they had an RT score of less than 
3,000 (9 children) or greater than 3,000 (16 children), since some regression-
scattergrams showed a drop of the test scores environs an RT score of 3,000. 
Comparison of the two subgroups revealed significant differences for PIQ, for the 
Wechsler performance subtests Picture Arrangement and Block Design, and for the 
Visual Attention test (Table VII). 
 
Therefore, it appears that the degree of deterioration in general cognition (Picture 
Arrangement, and the parameter "Decline" which approaches significance in Table VII), 
in attention, and in visual-spatial skills (PIQ, Block Design, and Coding which also 
approaches significance in Table VII), correlates significantly with the total dose of RT. 
Since an RT score lower than 3,000 corresponds to involved field radiation without 
whole-brain RT (Table I), it might be assumed that the addition of whole-brain RT to 
the conventional doses administered adds a significant risk of greater compromise for 
the specific intellectual functions which tend to be affected. 
DISCUSSION 
 
The radiation doses used in the treatment of ICT induces a neuropsychological 
deterioration clearly different from that produced by the action of the tumor itself. This 
deterioration was not seen in children suffering from CHR nor in children with ECT 
who had received more intense CT (the mean of CT score for the ICT group was 8.7 
and for the ICT group 1.1). 
 
There is some controversy of whether or not, when administered together, CT (mainly 
MTX) and RT potentiate their effect on normal CNS [4,24]. However, given that only 
11 of the children with ICT in this study received neurotoxic drugs with radiation, and 
this CT was in low dose, and having controlled other variables by the research design, 
the deterioration observed appears to be largely attributable to RT. Hydrocephaly might 
also contribute to the deterioration observed. However, Ellenberg et al. [25] have 
suggested that acute hydrocephaly, in contrast to its chronic form, has not been shown 
to be an important contributing factor in neuropsychological deterioration since its 
effects are transitory. Once eliminated, attentional function is restored and bradypsychia 
disappears. 
 
Children who received RT for middle edge cerebral tumors deteriorated most in visual 
and verbal memory (Yuste Memory Test and Rey Complex Figure Memory Test), that 
is, in the ability to identify something as meaningful and to process it in such a way that 
it can later be remembered; in attention capacity and visual discrimination skills (Visual 
Attention Test and the Wechsler performance subtests Picture Completion and Coding 
Tests); in verbal fluency (ITPA Verbal Fluency Test) involving agility in verbalized 
thinking; and in manual praxias (PIQ and its Object Assembly and Block Design 
subtests), which measure perception of spatial relations, eye-hand coordination, and 
anticipatory-sequencing-strategy skills. In summary, children who underwent brain 
irradiation deteriorated in a number of specific cognitive functions: the most affected 
was memory, followed by attention capacity, verbal fluency, and sequential processing. 
Duffner et al. [8,26], Kun and Mulhern [27], Packer et al. [28], Bendersky et al. [29], 
and Morrow et al. [30] have also found selective deficiencies in memory, attention 
ability, and visual-spatial organizational skills. 
  
The functional circuit to which attentional and memorial abilities refer is composed of 
the reticular ascending substance and the limbic-mammillo-thalamic-neostriate-
orbitomesial connections [31-35]. All these structures are usually located in the cone-
down fields of the irradiation to boost regions in the middle-edge of the intracranial 
content. Moreover, this latter circuit influences the selective activation or inhibition of 
all the convex areas which are directly affected in most cases by the whole-brain RT 
[36-38]. A reduction in whole-brain radiation would decrease the damage to the cortical 
and the subcortical white matter of the convexity (in relation to the intramodal and 
intermodal associative functions: information-processing tasks), improving the 
information transmission and associative functions. Perhaps dosages similar to those 
used in meningeal prophylaxis in children with leukemia would be sufficient to sterilize 
any possible micrometastases of the ICT. It is controversial whether or not such a 
reduction would be preferable also from the point of view that these lower dosages 
produce a less significant deterioration in neuropsychological functions [39,40]. Tomita 
and Mclone [41], Brand et al. [42], and Halberg et al. [43] have shown that the 
prophylactic radiation dose to the cranial-spinal axis can be decreased without 
jeopardizing control rate and survival in patients, mainly in those low risk patients who 
have had a total surgical tumor resection and negative myelography and cerebrospinal 
fluid cytology. 
 
Three-dimensional treatment techniques, and target volumen estimations performed 
with magnetic resonance imaging (that try to avoid structures related to attentional and 
memorial functions in the cases where they are not affected by the tumor), will permit 
more accurate design of treatment programs that will attempt to decrease the long-term 
sequelae of ICT patients and no compromise of disease control rates. 
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Table 1. Data Relating to the Patients, Their Tumors, and the RT Received 
Type of tumor 
Age at 
RT 
(years) 
Interval to 
assessment 
(months) 
Whole-brain 
RT 
(cGy) 
Involved 
RT  
(cGy) 
Ratio
a
 
Score 
RT
b
 
1. Medulloblastoma (posterior fossa) 12 6 3,000 2,000 0.27 4,396 
2. Medulloblastoma (posterior fossa) 6 7 2,600 3,000 0.20 3,768 
3. Pons oligodendroglioma (middle fossa) 2 7  5,000 0.51 2,527 
4. Astrocytoma IV v. (posterior fossa) 15 7 3,000 2,000 0.15 3,752 
5. Thalamic multiform glioma (middle fossa) 12 8 3,000 2,000 0.22 4,075 
6. Medulloblastoma (posterior fossa) 14 8 3,000 2,000 0.15 3,751 
7. Pineal tumor (middle fossa) 7 14 3,000 2,000 0.13 3,671 
8. Optic glioma (anterior fossa) 13 18  6,000 0.65 3,900 
9. Ependymoma IV v. (posterior fossa) 15 18 3,000 2,600 0.2 4,099 
10. Medulloblastoma (posterior fossa) 14 28 3,000 2,600 0.14 3,771 
11. Ependymoma IV v. (posterior fossa) 4 33 3,000 2,000 0.17 3,837 
12. Optochiasmatic glioma (anterior/middle fossa) 2 35  5,600 0.42 2,357 
13. Optic glioma (anterior fossa) 4 35  5,400 0.17 903 
14. Cerebellar astrocytoma (posterior fossa) 9 37  5,800 0.35 2,030 
15. Ependymoma IV v. (posterior fossa) 8 38 2,600 2,800 0.24 3,884 
16. Ependymoma IV v. (posterior fossa) 2 48 3,000 2,400 0.21 4,108 
17. Astrocytoma floor III v. (middle fossa) 9 48  6,000 0.5 3,000 
18. Optic glioma (anterior fossa) 2 56  5,000 0.16 800 
19. Optic glioma (anterior fossa) 5 60  5,000 0.17 824 
20. Medulloblastoma (posterior fossa) 2 74 3,200 1,600 0.15 3,940 
21. Optochiasmatic astrocytoma (anterior/middle fossa) 5 77  4,839 0.47 2,278 
22. Brain stem glioma (middle fossa) 6 120  9,360 0.7 6,595 
23. Medulloblastoma (posterior fossa) 9 120 4,000 1,200 0.11 4,580 
24. Medulloblastoma (posterior fossa) 9 120 3,000 2,000 0.18 3,900 
25. Cerebellar astrocytoma (posterior fossa) 15 120  4,950 0.37 1,833 
b
eGy of whole-brain RT + (cGy of involved field RT x the ratio
a
 of brain volume included in the boost). 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Diseases in the ECT and CHR Groups 
1. Osteoblastic osteosarcoma (left humerus) 
Portal hypertension with bloody esophagic 
varices 
2. Chondroblastic osteosarcoma (right femur) Crohn's disease 
3. Acute lymphoblastic leukemia (no RT given) 
Juvenile rheumatoid arthritis (Still's 
disease) 
4. Osteoblastic osteosarcoma (right humerus) Disseminated lupus erythematosus 
5. Osteoblastic osteosarcoma (right femur) Crohn's disease 
6. Osteoblastic osteosarcoma (left tibia) 
Juvenile rheumatoid arthritis (Still's 
disease) 
7. Osteoblastic osteosarcoma (right tibia) Polyarticular rheumatoid arthritis 
8. Osteoblastic osteosarcoma (right femur) 
Juvenile rheumatoid arthritis (Still's 
disease) 
9. Osteoblastic osteosarcoma (left femur) 
Important scoliosis (operated, long 
immobilization) 
10. Osteoblastic osteosarcoma (right tibia)  
Juvenile rheumatoid arthritis (Still's 
disease) 
11. Abdominal lymphoblastic lymphoma (T cells) Mucoviscidosis 
12. Cervical lymphoblastic lymphoma (T cells) Polyarticular rheumatoid arthritis 
13. Rhabdomyosarcoma (urinary bladder) Polyarticular rheumatoid arthritis 
14. Osteoblastic osteosarcoma (left femur) 
Juvenile rheumatoid arthritis (Still's 
disease) 
15. Ewing sarcoma (left femur) Turner's syndrome (limbs lengthening) 
16. Hodgkin's disease (IV A) 
Fallot tetralogy (several endocarditis, 
pacemaker) 
17. Suprarenal neuroblastoma Mucoviscidosis 
18. Ewing sarcoma (left perone) Polyarticular rheumatoid arthritis 
19. Suprarenal neuroblastoma Polyarticular rheumatoid arthritis 
20. Pheochromocytoma Primary amyloidosis 
21. Ewing sarcoma (fifth rib left) 
Chronic autoimmune hepatopathy (several 
biopsies) 
22. Ewing sarcoma (left tibia) 
Juvenile rheumatoid arthritis (Still's 
disease) 
23. Ewing sarcoma (left tibia) Chronic granulomatous disease 
24. Osteoblastic osteosarcoma (left femur) 
Active chronic hepatitis (aggressive 
evolution) 
25. Wilms' tumor  Crohn's disease 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3. Neuropsychological Evaluation* 
 
General cognition    FSIQ (WISC) 
   Picture Arrangement (WISC)  
   Arithmetics (WISC)  
   Comprehension (WISC) 
Language    VIQ (WISC) 
   Vocabulary (WISC)  
    Articulation (S. Bentón)  
    Sentence Memory (S. Bentón) 
   Verbal Fluency (ITPA)  
   Similarities (WISC)  
   Information (WISC) 
Visual spatial skills   PIQ (WISC) 
   Copy Rey Complex Figure Block Designs (WISC)  
   Object Assembly (WISC)  
   Picture Completion (WISC)  
   Coding (WISC) 
   Attention Test (Thurstone) 
Memory    Digit Span (WISC) 
   Metnory Test (Yuste) 
   Sequential Visual-Motor Memory (ITPA)  
   Memory Rey Complex Figure 
Reading, writing    Arbitrary Writing Errors (TALE) 
   Natural Writing Errors (TALE)  
   Reading Test (TALE) 
 
*This distribution of the tests and subtests permits us to evaluate the different specific 
functions and construct a neuropsychological profile for each patient. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4. Descriptive Statistics of the Three Groups 
 
ICT ECT CHR 
Mean SD Mean SD Mean SD 
1. FSIQ 92.04 22.25 107.04 11.60 106.92 10.26 
2. VIQ 97.78 14.74 102.92 11.02 103.08 12.59 
3. PIQ 93.48 19.03 110.13 12.41 107.4 10.63 
4. Picture Arrangement (WISC) 10 3.22 11.71 2.44 12.42 1.82 
5. Arithmetic (WISC) 9.54 3.42 10.75 2.35 11.08 2.69 
6. Comprehension (WISC) 9.5 2.43 10.38 2.45 10.72 2.30 
7. Vocabulary (WISC) 10.83 2.33 11.13 2.03 11.36 2.23 
8. Articulation (S. Bentón)a 27.78/30 2.92 28.41/30 1.72 27.96/30 2.25 
9. Sentence Memory (S. Bentón)a 22.17/26 3.46 23.62/26 2.65 23.92/26 2.91 
10. Verbal Fluency (ITPA)a 68.35 21.22 86.67 23.12 87.16 24.39 
11. Similarities (WISC) 10.52 3.09 11.92 1.98 11.48 2.14 
12. Information (WISC) 9.87 2.55 9.96 2.74 9.88 3.02 
13. Copy Rey Figureb 41.52 19.86 52.01 12.09 51.1 9.55 
14. Block Designs (WISC) 10.41 3.17 12.46 3.70 11.76 2.40 
15. Object Assembly (WISC) 9.74 3.47 12.83 3.41 11.17 2.12 
16. Picture Completion (WISC) 9.11 2.75 10.83 2.06 10.33 2.06 
17. Attention Testh 38.36 14.78 54.69 10.54 53.55 7.75 
18. Coding (WISC) 7.94 4.07 11.17 2.62 11.87 3.15 
19. Digit Span (WISC) 9 3.27 10.14 2.63 10.63 2.43 
20. Memory Test (Yuste)b 37.29 9.85 49.01 8.06 51.92 10.46 
21. Sequential Visual-Motor          
Memory (ITPA)
a
 
15.78/26 5.04 18.83/26 4.02 17.4/26 4.66 
22. Memory Rey Figureb 45.80 14.46 55.66 8.50 54.66 10.08 
23. Arbitrary Writing Errors (TALE)c 5.32 5.09 5.54 4.21 6.7 4.56 
24. Natural Writing Errors (TALE)c 3.5 5.31 1.42 1.99 1.7 2.51 
25. Reading Test (TALE)c 7.32 7.25 6.04 5.54 7.22 6.16 
a
Direct results. The denominator following oblique denotes maximum score of the test. For 
Verbal Fluency direct results are also given (number of words spoken). We could not obtain 
normalized results because these tests are not standardized for Spanish population for ages of 
our patients. 
b
Normalized results (mean 50 SD10). Other tests are WISC subtests (mean 10 SD3). 
c
Direct results (number of errors made).  
 
 
 
 
 
Table 5. One-Way Variance Analysis Among the Three Groups (Data With Normal 
Uniform Distribution) 
 
ANOVA 
P 
ICT vs. ECT 
F2,72 
ICT vs. CHR 
F2,72 
ECT vs. CHR 
F2,72 
FSIQ 0.001 5.752
a
 5.651
a
 3.7E-4 
VIQ 0.281 0.938 1.019 0.001 
PIQ 0.0003 7.895
a
 5.632
a
 0.221 
Comprehension 0.213 0.748 1.505 0.127 
Vocabulary 0.703 0.108 0.353 0.071 
Articulation 0.638 0.421 0.035 0.226 
Sentence Memory 0.111 1.357 2.004 0.058 
Verbal Fluency 0.005 3.692
a
 4.971
a
 0.091 
Similarities 0.142 1.924 0.926 0.197 
Information 0.992 0.006 8.4E-5 0.005 
Block Designs 0.077 2.569 1.149 0.306 
Picture Completion 0.038 3.241
a
 1.617 0.285 
Memory Test 0.0001 8.894
a
 14.14
a
 0.573 
Sequential Visual-Motor Memory 0.081 2.602 0.746 0.599 
a
Statistical significant differences. 
 
 
 
Table 6. Nonparametric Variance Analysis Among the Three Groups (Data With 
Neither Normal Nor Uniform Distribution) 
 
Kruskal-Wallis U Mann-Whitney 
P 
ICT vs. ECT 
P 
ICT vs. CHR 
P 
ECT vs. CHR 
P 
Picture Arrangement 0.007* 0.032* 0.002* 0.364 
Arithmetic 0.129 0.112 0.065 0.613 
Copy Rey Figure 0.147 0.063 0.169 0.496 
Object Assembly 0.009* 0.004* 0.115 0.059 
Attention Test 0.0001* 0.0002* 0.0002.* 0.836 
Coding 0.001* 0.003* 0.0008* 0.433 
Digit Span 0.260 0.269 0.099 0.721 
Memory Rey Figure 0.017* 0.008* 0.022* 0.741 
Arbitrary Writing Errors 0.358 0.564 0.147 0.416 
Natural Writing Errors 0.093 0.057 0.066 0.735 
Reading Test 0.841 0.715 0.918 0.542 
*Statistically significant differences. 
Table 7. Levels of Statistical Significance Obtained From a Comparison of Test Results 
of Children Irradiated With a Score of RT Greater and Less Than 3,000 
          P      Tests applied 
FSIQ    0.2263    t-test 
VIQ    0.5312    t-test 
PIQ   0.0265*   t-test 
Picture Arrangement    0.0373*  U-Mann-Whitney 
Arithmetic   0.1349   U-Mann-Whitney 
Comprehension   0.3792    t-test 
Vocabulary   0.322    t-test 
Articulation   0.1706    t-test 
Sentence Memory   0.2989    t-test 
Verbal Fluency   0.3738    t-test 
Similarities   0.1687    t-test 
Information   0.8624    t-test 
Copy Fey Figure   0.9228   U-Mann-Whitney 
Block Design   0.0565*   t-test 
Object Assembly   0.1118   U-Mann-Whitney 
Picture Completion   0.1077    t-test 
Attention Test   0.0201*  U-Mann-Whitney 
Coding   0.0802   U-Mann-Whitney 
Digit Span   0.7039   U-Mann-Whitney 
Memory Test   0.2223    t-test 
Sequential Visual-Motor Memory  0.3625    t-test 
Memory Rey Figure   0.5849   U-Mann-Whitney 
Arbitrary Writing Errors   0.4983    t-test 
Natural Writing Errors   0.5309    t-test 
Reading Test   0.3974    t-test 
FSIQ Decline
a
   0.0834    t-test 
 
* Statistically significant differences. 
a 
Result obtained by subtracting the preillness and post-RT FSIQ. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. FSIQ deterioration in children irradiated for ICT. Short-term follow-up:          
6 months to 3 years post-RT (13 patients), long-term follow-up: 3 years to 10 years 
post-RT (12 patients). See Table I. 
